— Know what they know.
Not Investment Advice

NUMD OTC

Nu-Med Plus, Inc.
1W: -36.5% 1M: -40.2% 3M: +33.3% YTD: +2.8% 1Y: -53.2% 3Y: -36.5% 5Y: -88.8%
$0.01
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Devices · Tech Score Strong Sell · Power 33 · $1.2M mcap · 46M float · 0.036% daily turnover · Short 53% of daily vol
Smart Money Score
No convergence signal
Key Statistics
Market Cap$1.2M
52W Range0.0095-0.037
Volume3,424
Avg Volume16,415
Beta-2.29
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOWilliam R. Colvin
Employees2
SectorHealthcare
IndustryMedical - Devices
IPO Date2014-09-25
640 Belle Terre Road
Port Jefferson, NY 11777
US
801 746 3570
About Nu-Med Plus, Inc.

Nu-Med Plus, Inc. is a global medical technology firm dedicated to the innovation, refinement, and commercialization of various medical instruments. The company's offerings include a diverse array of nitric oxide delivery systems, such as specialized units for hospital environments, clinical applications, and research settings, alongside a mobile, rechargeable device designed for portable nitric oxide gas administration. Serving a broad spectrum of healthcare entities, its primary clients consist of hospitals, integrated health systems, and the wider medical professional community. Nu-Med Plus, Inc. was founded in 2011 and maintains its corporate headquarters in Salt Lake City, Utah.

Latest News
No recent news

Recent Insider Trades

NameTypeSharesPriceDate
TEJADA FRED J-Other 16,381,250 — 2026-07-08
TEJADA FRED A-Award 1,000,000 — 2026-07-08
TEJADA FRED A-Award 129,782 — 2026-07-08
TEJADA FRED 0 — 2026-07-07
Robins Jeffrey Lynn A-Award 200,000 $0.02 2023-11-07

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms